Dalid, Moises P.
HRN: 06-35-24 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/02/2023
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
02/02/2023
02/09/2023
IV
750mg
OD Every Other Day
Progressing Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes